This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 revenue up 22 percent, PAT up 8 percent
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 1.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Q2 FY27 revenue rose 22.1 percent to Rs 5,430.23 million (Rs 4,447.99 million a year ago) and PAT rose 8.3 percent to Rs 818.93 million. Half-year revenue was Rs 10,180.08 million and PAT Rs 1,464.33 million; EPS was Rs 8.10. Auditors gave a clean limited review. The group consolidated Super Prime Medical Care LLP from August 14 after buying 64 percent for Rs 198.40 million.
Revenue growth above 22 percent is positive, but PAT rose only 8 percent and finance costs rose, so the stock reaction may be muted.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹548.0 Cr | ₹444.8 Cr | +23.2% |
| Operating profit | ₹103.4 Cr | ₹94.18 Cr | +9.8% |
| Profit after tax | ₹83.89 Cr | ₹75.62 Cr | +10.9% |
| EBITDA margin | 31.0% | 33.5% | −2.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.